The European Society for Medical Oncology (ESMO) released today the ESMO Guidance on the Use of Large Language Models in ...

A novel combination therapy pairing a DNA-synthesis inhibitor with a targeted radiopharmaceutical may improve outcomes for ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced results from the randomized, double-blind, phase 3 ...

The latest update is out from Race Oncology Ltd. ( (AU:RAC) ).

BERLIN -- The investigational tyrosine kinase inhibitor (TKI) zanzalintinib plus atezolizumab (Tecentriq) significantly ...

The state-of-the-workforce report identifies challenges in cancer care access across the US, particularly in rural areas.

The study investigators concluded that EV+P demonstrated activity in advanced urothelial carcinoma tumors with histologic subtype component, including pure histologic subtypes and variants which have ...

(NASDAQ:MRNA) today announced that clinical, safety and translational data from its Phase 1/2 study evaluating mRNA-4359 in ...

The ELCAP guidance sets standards for responsible AI use in oncology, protecting patients and supporting clinicians LUGANO, Switzerland and BERLIN, Oct. 20, 2025 /PRNewswire/ ...

Dr. Laurence Albiges presented the poster Characteristics and real-world adherence to ESMO guidelines of patients with advanced Renal Cell Carcinoma (aRCC) in the era of immuno-oncology-based (IO) ...

At 72, Judith McDaniel, a former oncology nurse, experienced cancer treatment after a routine mammogram led to her diagnosis ...

Penn State Health held a bell-ringing ceremony on Monday, Oct. 20, for a new cancer center that will open in Enola. The Penn ...